Nivolumab in non-small-cell lung cancer with EGFR mutation

被引：37

作者：

Yoshida, H. ^{[1
]}

Kim, Y. H. ^{[1
]}

Ozasa, H. ^{[1
]}

Nagai, H. ^{[1
]}

Sakamori, Y. ^{[1
]}

Tsuji, T. ^{[1
]}

Nomizo, T. ^{[1
]}

Yasuda, Y. ^{[1
]}

Funazo, T. ^{[1
]}

Hirai, T. ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷 / 03期

关键词：

PD-L1;

D O I：

10.1093/annonc/mdx745

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：777 / 778

页数：2

共 5 条

[1]

[Anonymous], CANC RES S

[2] Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall- cell lung cancer [J].

Azuma, K. ;

Ota, K. ;

Kawahara, A. ;

Hattori, S. ;

Iwama, E. ;

Harada, T. ;

Matsumoto, K. ;

Takayama, K. ;

Takamori, S. ;

Kage, M. ;

Hoshino, T. ;

Nakanishi, Y. ;

Okamoto, I. .

ANNALS OF ONCOLOGY, 2014, 25 (10) :1935-1940

[3] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[4] Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer A Meta-Analysis [J].

Lee, Chee Khoon ;

Man, Johnathan ;

Lord, Sally ;

Links, Matthew ;

Gebski, Val ;

Mok, Tony ;

Yang, James Chih-Hsin .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) :403-407

[5] Classifying Cancers Based on T-cell Infiltration and PD-L1 [J].

Teng, Michele W. L. ;

Ngiow, Shin Foong ;

Ribas, Antoni ;

Smyth, Mark J. .

CANCER RESEARCH, 2015, 75 (11) :2139-2145

← 1 →